Ions pharma stock
WebThe Ionis antisense pipeline. Our antisense technology platform has served as a springboard for drug discovery and realized hope for patients with unmet needs. Our broad, diverse pipeline has more than 40 potential first-in-class and/or best-in-class medicines designed to treat a broad range of diseases. Web6 apr. 2024 · The current IONS price target is $45.33. Learn why top analysts are making this price prediction for Ionis Pharmaceuticals at MarketBeat. ... According to analysts, …
Ions pharma stock
Did you know?
WebIONIS PHARMACEUTICALS, INC. : Financial analyst guidance for IONIS PHARMACEUTICALS, INC. Stock Berne Stock Exchange: IONS Berne Stock Exchange Web10 apr. 2024 · Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular …
WebOur platform has served as a springboard for drug discovery and realized hope for patients with unmet needs. Our broad, diverse pipeline has more than 40 first-in-class and/or best-in-class medicines designed to treat a broad range of diseases. Web12 apr. 2024 · Ionis Pharmaceuticals Stock Up 0.9 %. Shares of Ionis Pharmaceuticals stock opened at $37.23 on Tuesday. Ionis Pharmaceuticals has a 1 year low of $31.46 and a 1 year high of $48.82. The stock has ...
WebIonis Pharmaceuticals Inc Follow Share $37.23 After Hours: $37.23 (0.00%) 0.00 Closed: Apr 11, 7:29:48 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Crispr … Web29 mrt. 2024 · We Are Transforming the Standard of Care and Pioneering New Markets. As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused …
WebIonis Pharma Inc IONS. NASDAQ $36.00 2.01 % +$0.71. Day Range. Day Range. The total range of the associated security's price quotes as of market open. ... Stock prices can …
Web17 mrt. 2024 · Ionis Pharmaceuticals stock is currently +11.82% from its 52-week low of $31.46, and -27.94% from its 52-week high of $48.82. At the moment, there are 142.95M IONS shares outstanding. The market capitalization of IONS is $5.03B. In the past 24 hours, 1.45M IONS shares were traded. c# sort list by datetimeWebFor the quarter ended 31/12/2024, Ionis Pharmaceuticals's revenues decreased by 4.86% and amounted to 152.00M. Net income decreased by 10.66% to -52.00M. Net assets decreased by 3.59% to 573.00M and EPS decreased from -0.33 to -0.37. IONS's Investor Relations. Income Statement Balance Sheet Cash Flow Statement. ealing broadway phone shopWebOn average, Wall Street analysts predict. that Ionis Pharmaceuticals's share price could reach $46.64 by Mar 21, 2024. The average Ionis Pharmaceuticals stock price … c# sort list of objects by datetime propertyWebIonis Pharmaceuticals (IONS) Reports Q4 Loss, Misses Revenue Estimates. Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of 65.09% and … c# sort list of array of intWeb3 mrt. 2024 · In December 2024 we talked about how Ionis Pharmaceuticals stock (NASDAQ: IONS) seems to be oversold, and since then the stock has seen a 15% rise … c# sorting datagrid with listWeb12 apr. 2024 · Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a … ealing broadway pedicureWeb31 mrt. 2024 · Company. Ionis Pharmaceuticals, Inc. is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The Company is primarily … csor training doj